174 related articles for article (PubMed ID: 8623228)
1. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats.
Masubuchi Y; Kawaguchi T; Ohtsuki M; Suzuki C; Amano Y; Hoshino Y; Chiba K
Transplant Proc; 1996 Apr; 28(2):1064-5. PubMed ID: 8623228
[No Abstract] [Full Text] [Related]
2. The effect of tilorone on the local graft-versus-host reaction in rats.
Megel H; Raychaudhuri A; Thomas LL
Transplantation; 1976 Jan; 21(1):81-3. PubMed ID: 1883
[No Abstract] [Full Text] [Related]
3. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
Xia W; Brandeis JM; Sayegh M; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013
[No Abstract] [Full Text] [Related]
4. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
Schorlemmer HU; Kurrle R; Bartlett RR
Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
[No Abstract] [Full Text] [Related]
5. Functional analysis of cells present within a popliteal lymph node after a "regional" graft-versus-host reaction in the rat.
Lang P; Charpentier B; Martin B; Cividino N; Fries D
Transplant Proc; 1981 Jun; 13(2):1444-9. PubMed ID: 6454288
[No Abstract] [Full Text] [Related]
6. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction.
Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE
Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956
[No Abstract] [Full Text] [Related]
7. Suppressor cell system in immunoregulation of the local graft-versus-host reaction (GVHR).
Lang P; Charpentier B; Martin B; Fries D
Transplant Proc; 1979 Sep; 11(3):1617-21. PubMed ID: 41348
[No Abstract] [Full Text] [Related]
8. The effects of various routes of administration of monoclonal anti-T cell antibodies for prevention of the graft-versus-host reaction following small bowel transplantation.
Johnsson C; Tufveson G
Transplantation; 1994 Jan; 57(2):289-92. PubMed ID: 8310522
[No Abstract] [Full Text] [Related]
9. Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides.
Schorlemmer HU; Bartlett RR; Kurrle R
Transplant Proc; 1998 Jun; 30(4):968-70. PubMed ID: 9636391
[No Abstract] [Full Text] [Related]
10. Regional graft-versus-host and host-versus-graft reactions: histology of the popliteal lymph nodes.
Korcáková L; Holub M; Hasková V
Folia Biol (Praha); 1974; 20(5):309-13. PubMed ID: 4155380
[No Abstract] [Full Text] [Related]
11. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
Schorlemmer HU; Kurrle R; Bartlett RR
Drugs Exp Clin Res; 1997; 23(5-6):167-73. PubMed ID: 9515226
[TBL] [Abstract][Full Text] [Related]
12. Development of graft-versus-host reaction in various target organs after small intestine transplantation.
Deltz E; Müller-Hermelink HK; Ulrichs K; Thiede A; Müller-Ruchholtz W
Transplant Proc; 1981 Mar; 13(1 Pt 2):1215-6. PubMed ID: 6973862
[No Abstract] [Full Text] [Related]
13. Responsive cells in graft-versus-host reaction and its regulatory mechanism.
Yamashita A; Hattori Y; Mito M; Miyamoto M
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1598-605. PubMed ID: 3502310
[No Abstract] [Full Text] [Related]
14. Cellular events in tolerance. IV. The effect of a graft-versus-host reaction and endotoxin on hapten- and carrier-specific tolerance.
Ornellas EP; Sanfilippo F; Scott DW
Eur J Immunol; 1974 Sep; 4(9):587-91. PubMed ID: 4154199
[No Abstract] [Full Text] [Related]
15. Disseminated expression of a "regional" graft-versus-host reaction (GVHR): detection of a new system of GVHR resistance.
Lang P; Charpentier B; Martin B; Cividino N; Fries D
Transplant Proc; 1981 Mar; 13(1 Pt 2):1226-30. PubMed ID: 6973863
[No Abstract] [Full Text] [Related]
16. The effect of Escherichia coli endotoxin on the graft-versus-host reaction in mice. 3. Runt disease in newborns.
Skopińska E
Arch Immunol Ther Exp (Warsz); 1974; 22(3):305-8. PubMed ID: 4151942
[No Abstract] [Full Text] [Related]
17. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
18. Dietary lipid modulation of cell mediated immunity in the rat.
Sanderson P; Yaqoob P; Calder PC
Biochem Soc Trans; 1995 May; 23(2):273S. PubMed ID: 7672299
[No Abstract] [Full Text] [Related]
19. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice.
Kataoka H; Ohtsuki M; Shimano K; Mochizuki S; Oshita K; Murata M; Sugahara K; Sato N; Hoshino Y; Chiba K
Transplant Proc; 2005; 37(1):107-9. PubMed ID: 15808562
[No Abstract] [Full Text] [Related]
20. Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease.
Schorlemmer HU; Bartlett RR; Kurrle R
Transplant Proc; 1997; 29(1-2):1298-301. PubMed ID: 9123315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
